glucagon like peptide 1 glp 1 Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Glucagon-like peptide-1: Trends in Endocrinology

Description

GLP-1 and Reproduction You have GLP-1 receptors throughout the body, including the reproductive system, in the ovaries and uterus

acquires Polynoma + secures $25M funding to advance phase 3 cancer vaccine Regeneron's Libtayo PD-1 inhibitor lands FDA adjuvant therapy approval in squamous cell carcinoma UK government considers raising NICE - National Institute for Health and Care Excellence cost-effectiveness threshold to increase NHS drug spending For all the news, check out the full (free) TLDR Biotech newsletter here ---------------------------------------- One skimmable email per day to keep up with biotech and pharma Big thanks to Promoveo Health for supporting this newsletter - they've built 100+ pharma sales teams for companies of all sizes, and they can do it for your org as well

The nations largest pharmacy benefit managers CVS Caremark, Express Scripts, and Optum Rx will now include Zepbound and Foundayo in their formularies, per Lilly

Common GLP-1 Side Effects According to clinical literature and FDA labeling for approved GLP-1 medications, commonly reported side effects include nausea (especially when starting or after dose increases), vomiting, diarrhea, constipation, abdominal discomfort, decreased appetite, fatigue, and injection site reactions (for injectables)